DDX21 and colorectal carcinoma: Moreover, upregulation of DDX21 was correlated with poor Overall Survival (OS) rate and Disease-free Survival (DFS) in stage III and IV CRC patients (Fig. 1F, G), rather than among all stage or stage I and II (Fig. S1E–H), indicating DDX21 may have potential role in late stage CRC.